- Home
- GBIO vs GAME Comparison
GBIO vs GAME Comparison
Compare GBIO & GAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBIO
- GAME
- Stock Information
- Founded
- GBIO 2016
- GAME 2011
- Country
- GBIO United States
- GAME United States
- Employees
- GBIO N/A
- GAME N/A
- Industry
- GBIO Biotechnology: Pharmaceutical Preparations
- GAME
- Sector
- GBIO Health Care
- GAME
- Exchange
- GBIO Nasdaq
- GAME Nasdaq
- Market Cap
- GBIO 29.2M
- GAME 27.2M
- IPO Year
- GBIO 2020
- GAME 2009
- Fundamental
- Price
- GBIO $0.37
- GAME $1.86
- Analyst Decision
- GBIO Strong Buy
- GAME Strong Buy
- Analyst Count
- GBIO 4
- GAME 3
- Target Price
- GBIO $7.33
- GAME $3.67
- AVG Volume (30 Days)
- GBIO 1.1M
- GAME 7.1M
- Earning Date
- GBIO 08-06-2025
- GAME 08-13-2025
- Dividend Yield
- GBIO N/A
- GAME N/A
- EPS Growth
- GBIO N/A
- GAME N/A
- EPS
- GBIO N/A
- GAME N/A
- Revenue
- GBIO $24,556,000.00
- GAME $99,579,536.00
- Revenue This Year
- GBIO N/A
- GAME $6.08
- Revenue Next Year
- GBIO N/A
- GAME $21.94
- P/E Ratio
- GBIO N/A
- GAME N/A
- Revenue Growth
- GBIO 146.47
- GAME 77.06
- 52 Week Low
- GBIO $0.30
- GAME $0.50
- 52 Week High
- GBIO $3.65
- GAME $2.87
- Technical
- Relative Strength Index (RSI)
- GBIO 52.02
- GAME 75.08
- Support Level
- GBIO $0.32
- GAME $0.73
- Resistance Level
- GBIO $0.36
- GAME $2.87
- Average True Range (ATR)
- GBIO 0.03
- GAME 0.22
- MACD
- GBIO 0.00
- GAME 0.13
- Stochastic Oscillator
- GBIO 81.00
- GAME 53.88
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is engaged to revolutionize the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. Its next generation media, entertainment, and technology help creators and maximize its brand partners return on investment. Its purpose-built platform, provide marketing and creative services, offer data and analytics solutions, and amplify awareness through FaZe Clan.